Intravitreal Bevacizumab for Non-Arteritic Anterior Ischemic Optic Neuropathy

Clinical trial NCT00813059 · UNKNOWN

Trial details

NCT number: NCT00813059
Sponsor: Mount Sinai Hospital, Canada
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-arteritic Anterior Ischemic Optic Neuropathy

Start date: 2009-02-01
Primary completion: 2012-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.